Tenaya Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $17,664 |
Gross Profit | -2,123 | -2,155 | 14,677 |
EBITDA | -28,700 | -31,607 | -29,265 |
EBIT | -30,823 | -33,762 | -32,252 |
Net Income | -29,431 | -32,228 | -29,935 |
Net Change In Cash | 0 | 0 | 17,664 |
Free Cash Flow | -23,690 | -29,224 | -22,318 |
Cash | 58,134 | 59,303 | 45,681 |
Basic Shares | 85,706 | 80,982 | 68,330 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8,687 | -8,713 | -4,025 | -2,483 |
EBITDA | -122,506 | -119,154 | -69,845 | -36,429 |
EBIT | -131,193 | -125,621 | -72,806 | -38,912 |
Net Income | -124,084 | -123,663 | -69,652 | -38,308 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 56,995 | -90,406 | ||
Free Cash Flow | -103,311 | -125,054 | -85,933 | -45,210 |
Cash | 45,681 | 95,272 | 38,129 | 128,535 |
Basic Shares | 73,786 | 44,823 | 41,291 | 41,124 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.30 |
2024-06-30 | -$0.34 |
2024-03-31 | -$0.40 |
2023-12-31 | -$0.40 |
